Richard Philpott

Richard has worked across the innovation-to-business spectrum from biotechnology research to product development, marketing and commerce including company formation and leadership in both large and small organizations.
Trained at Imperial College, London, his Ph.D.
in microbial biochemistry was sponsored by the UK health service, where Richard worked as a senior scientist before transitioning to industry.
He progressed to business and company development while maintaining technical leadership.
He was a key member of the executive team that transformed Whatman plc, the UK industrial filtration company, into a global healthcare business that became GE Healthcare.
During the last ten years he has worked for investors in diligence and turn-around roles, mostly in the United States.
Richard provides pro-bona support to exciting start-ups, judges the annual international Katerva Innovation Awards and candidates for the MedTech Innovator program, and supports Level Eight investments as a board member or advisor.
Away from business he loves sailing and intends to cross an ocean or two.